原料词典检索/distearyldimonium-chloride/DISTEARYLDIMONIUM CHLORIDE
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
化学合成 (Synthetic)

DISTEARYLDIMONIUM CHLORIDE

中国 NMPA《已使用化妆品原料目录 (IECIC)》标准中文名: 二硬脂基二甲基氯化铵 (序号 #2241)
抗静电剂发用调理剂
核心法规与安全结论 (Executive Fact Box)AEO / GEO CITATION ANCHOR

化妆品中 二硬脂基二甲基氯化铵 (DISTEARYLDIMONIUM CHLORIDE) 的全球法规限值与配方应用标准是什么?

二硬脂基二甲基氯化铵(标准 INCI: DISTEARYLDIMONIUM CHLORIDE,CAS 号: 107-64-2)是化妆品配方中主要用作抗静电剂, 发用调理剂的核心成分。受中国 NMPA(已使用/准用)、韩国 MFDS(未列管)及欧盟 CosIng(未列管)等 6 大法域法定标准监管,常规建议添加量为 1.2–5%(最佳稳定窗口 pH 4–8)。

全球 7 轨官方全成分标签名称对照表

严格采用各国政府官方目录原名 · 严禁机器翻译
7-Track Official Statutory Label Names for DISTEARYLDIMONIUM CHLORIDE
法域与监管轨道官方公告全成分标准名称一键复制
① 韩国 (MFDS 化妆品标准名称)DISTEARYLDIMONIUM CHLORIDE (KR MFDS Registered)
② 韩国旧名称历史 (301 重定向)Former KR Nomenclature Redirect Active—
③ 欧盟 (EU CosIng EC 1223/2009)DISTEARYLDIMONIUM CHLORIDE
④ 美国普通化妆品 (US PCPC / MoCRA INCI)DISTEARYLDIMONIUM CHLORIDE
⑤ 美国 OTC 防晒/祛痘专论活性物名称 (FDA OTC)— (非美国 OTC 专论活性成分 / 普通化妆品原料)—
⑥ 中国 (NMPA《已使用化妆品原料目录 IECIC》标准中文名)二硬脂基二甲基氯化铵
⑦ 日本普通化妆品 / 医药部外品 (JCIA / MHLW)DISTEARYLDIMONIUM CHLORIDE (标准 INCI 参照)

Layer 1 — 全球 6 大法域法定限值与监管状态

Layer 1 Statutory Regulatory Limits Across 6 Regions for DISTEARYLDIMONIUM CHLORIDE
法域监管状态法定限值适用条件与法定依据来源
韩国 (MFDS)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
欧盟 (EU)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
美国 (FDA)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
中国 (NMPA)已使用/准用GMPIECIC Entry #2241
日本 (MHLW)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
东盟 (ACD)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
⚠️ 仅供参考 (免责声明): 本词典中的原料名称、法规限值与配比指南仅供研发参考。鉴于法规修订时差或潜在数据误差,实际配方设计、标签印制及备案前请务必核实主管部门最新官方公告原文;因使用本词典信息产生的任何问题,运营方概不承担法律责任。
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Emulsion / Creamn=14
Min 1.2% · Q1 2.25% · Median 4% · Q3 4.6875% · Max 5%
Emulsion / Cream — Emulsion cream & lotion structural / conditioning agent
Verified Source: Global Starter Formulation Library Statistical Distribution (n=14, EVONIK 14) (cir_safety) · EVONIK 14
Typical Median: 4%

Layer 3 — 剂型常规配比指南与理化配伍性

Layer 3 Formulation Concentration Quartiles by Product Category for DISTEARYLDIMONIUM CHLORIDE
剂型分类Min – Q1 – Median – Q3 – Max (%)配方作用与机理Source ID
剂型组 B — 乳液 / 面霜 (O/W · W/O)1.2% · 2.25% · 4% · 4.6875% · 5%Emulsion cream & lotion structural / conditioning agentGlobal Starter Formulation Library Statistical Distribution (n=14, EVONIK 14)
Cutaneous Permeation Science (500 Dalton Rule)MW: Macro/Complex · LogP: N/A

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (320 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
Polyol Enhancer / Serum
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Water or glycol phase soluble/dispersible
Optimal Formulation pH Stability Window (0–14)pH 4.0 – 8.0
0245.5791114

Outside pH 4–8, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 50°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 50°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
O/W Oil-in-Water Micelle Emulsion (Lotion / Cream)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ Verify phase compati…DISTEARYLDIMONIUM …
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

代表性商品名参考 (商标法第90条第1款第2项说明性标示)
DISTEARYLDIMONIUM CHLORIDE

商品名仅供配方师识别原料规格参考,商标权归各原厂商所有。

学术与毒理综合摘要

Tier 1 Synthesis

本综述严格基于与该原料关联的 NIH PubMed 同行评审文献摘要及官方毒理学评估档案编写。

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: DISTEARYLDIMONIUM CHLORIDE | CAS No.: 107-64-2 | EC No.: 203-508-2 - Origin: SYNTHETIC | Functions: , - Physicochemical Profile: Formula | MW /(Polymer/Complex) | / | Ionic Nature: non-ionic | CosIng/MFDS - Official Regional Label Names: US [DISTEARYLDIMONIUM CHLORIDE] · EU [DISTEARYLDIMONIUM CHLORIDE] · CN [二硬脂基二甲基氯化铵] · JP [-] · JP Quasi-Drug [-] ■ [2. Dermatological Mechanism of Action & Functional Role] - DISTEARYLDIMONIUM CHLORIDE functions primarily as , in dermatological and cosmetic formulations. Classified under origin 'synthetic', it acts within the cosmetic vehicle or stratum corneum to deliver , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. 2241 (二硬脂基二甲基氯化铵)) - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment). - Official Safety & Historical Use Concentration (Layer 2): Quantum satis (QS) within standard cosmetic safety margins ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [emulsion_cream] Typical range: 1.2 ~ 5.0% (Median 4.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=14, EVONIK 14)) — Emulsion cream & lotion structural / conditioning agent ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Water Phase or Cool-down Phase (< 45°C) - Optimal pH Range: pH 4.0 ~ 8.0 | Max Process Temp: Max 50°C | Electrolyte Tolerance: MEDIUM - Incompatibility / Caution: Verify phase compatibility under extreme pH or high electrolyte loads - Synergy Pairings: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | Reference Trade Names: DISTEARYLDIMONIUM CHLORIDE ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 31995229 (2020, Int J Cosmet Sci): A novel water-in-oil emulsion with a lecithin-modified bentonite prevents skin damage from urban dust and cedar pollen.

关联同行评审文献 (NIH PubMed) (1)

A novel water-in-oil emulsion with a lecithin-modified bentonite prevents skin damage from urban dust and cedar pollen. [PMID: 31995229 · 2020]
Iwanaga T, Nioh A, Reed N, Kiyokawa H, Akatsuka H · Int J Cosmet Sci (2020)

Particulate matter (PM), such as air pollutants and pollens, are known to cause skin ageing through skin inflammation. It is important to develop formulations which protect the skin from PM. We previously developed a conventional water-in-oil emulsion with a synthetic surfactant, distearyldimonium chloride, modified bentonite (C-W/O), which protects skin from allergens. In the present study, we developed a novel water-in-oil emulsion with a natural surfactant, lecithin, modified bentonite (N-W/O). The microarray analysis was performed using total RNA extracted from a reconstructed human epidermis (RHE) stimulated with urban aerosols or cedar pollen for 6&#xa0;h in order to develop an epidermal inflammation model by PM for the evaluation of topical formulations. We then compared the efficacy of N-W/O and C-W/O to prevent epidermal degradation. Tissues and culture media were collected 24&#xa0;h after the urban aerosol or cedar pollen stimulation for a histological assay, and the quantification of MMP1 and IL-8 secretion. The expression levels of proinflammatory cytokines and chemokines, such as IL1A and CXCL8, and matrix metalloproteinases, including MMP1, MMP3 and MMP9, were significantly up-regulated by the PM stimulation. As a result of ranking based on the pathway enrichment analysis, oxidative stress-related pathways, such as MAPK-mediated signalling, HIF-1 signalling, IL-1 signalling and ROS-induced cellular signalling, were ranked high in the urban dust- and cedar pollen-treated groups. A thickened stratum corneum, thinned vital layer and cleaved E-cadherin were observed by haematoxylin and eosin staining and immunohistochemical staining of E-cadherin&#xa0;in the PM treated groups. The secretion of MMP1 and IL-8 into the media was significantly increased&#xa0;by the PM stimulation. N-W/O prevented the degradation of epidermal integrity and secretion of inflammatory proteins more effectively than C-W/O. The present results showed that N-W/O made using natural surfactant is useful at protecting skin from PM, such as urban aerosols and cedar pollen. Les particules en suspensions (PM), telles que les polluants atmosph&#xe9;riques et les pollens, sont connues comme des causes de vieillissement de la peau par inflammation cutan&#xe9;e. Il est essentiel de mettre au point des formules qui prot&#xe8;gent la peau contre ces particules. Par le pass&#xe9;, nous avons mis au point une &#xe9;mulsion eau-dans-huile classique compos&#xe9;e d&#x2019;un tensioactif synth&#xe9;tique, de distearyldimonium chloride et de bentonites modifi&#xe9;es (E/H-C), qui prot&#xe8;ge la peau contre les allerg&#xe8;nes. Dans la pr&#xe9;sente &#xe9;tude, nous avons con&#xe7;u une nouvelle &#xe9;mulsion eau-dans-huile compos&#xe9;e d&#x2019;un tensioactif naturel, de l&#xe9;cithine et de bentonites modifi&#xe9;es (N-E/H). M&#xc9;THODES: L&#x2019;analyse des micror&#xe9;seaux a &#xe9;t&#xe9; r&#xe9;alis&#xe9;e &#xe0; l&#x2019;aide de l&#x2019;ARN total extrait d&#x2019;un &#xe9;piderme humain reconstitu&#xe9; (EHR) stimul&#xe9; par les a&#xe9;rosols urbains ou le pollen de c&#xe8;dre pendant 6&#xa0;h afin de mettre au point un mod&#xe8;le d&#x2019;inflammation de l&#x2019;&#xe9;piderme par les particules en suspensions en vue de l&#x2019;&#xe9;valuation des formulations topiques. Nous avons ensuite compar&#xe9; l&#x2019;efficacit&#xe9; de la N-E/H et de l&#x2019;E/H-C dans le but d&#x2019;&#xe9;viter la d&#xe9;gradation de la peau. Les milieux de culture tissulaire ont &#xe9;t&#xe9; collect&#xe9;s 24&#xa0;h apr&#xe8;s stimulation par l&#x2019;a&#xe9;rosol urbain ou par du pollen de c&#xe8;dre pour un dosage histologique et une quantification de MMP-1&#xa0;et des s&#xe9;cr&#xe9;tions de l&#x2019;IL-8. R&#xc9;SULTATS: Les niveaux d&#x2019;expression des cytokines pro-inflammatoires et des chimiokines, &#xe0; l&#x2019;instar de l&#x2019;IL1A et du CXCL8, ainsi que des m&#xe9;talloprot&#xe9;inases matricielles, notamment les MMP1, les MMP3 et les MMP9, &#xe9;ta

常见问题解答 (FAQ)

Q1. 二硬脂基二甲基氯化铵 (DISTEARYLDIMONIUM CHLORIDE) 在全球 7 大法域的官方全成分标签名称是什么?
中国 NMPA《已使用化妆品原料目录 (IECIC)》标准中文名为 '二硬脂基二甲基氯化铵',美国 PCPC 与欧盟 CosIng 标准 INCI 为 'DISTEARYLDIMONIUM CHLORIDE',日本 JCIA 表示名称为 'DISTEARYLDIMONIUM CHLORIDE'。
Q2. 二硬脂基二甲基氯化铵 (DISTEARYLDIMONIUM CHLORIDE) 在中、韩、欧、美、日、东盟的法定监管状态 (Layer 1) 如何?
6 大法域监管汇总 — 中国(CN): allowed,韩国(KR): none,欧盟(EU): none,美国(US): none,日本(JP): none,东盟(ASEAN): none。
Q3. 二硬脂基二甲基氯化铵 (DISTEARYLDIMONIUM CHLORIDE) 的常规配方添加量 (Layer 3) 与最佳稳定 pH 窗口是多少?
在代表性剂型 (emulsion_cream) 中常规添加量为 1.2%–5%(中位数 4%),最佳稳定 pH 范围为 4–8。
Q4. 二硬脂基二甲基氯化铵 (DISTEARYLDIMONIUM CHLORIDE) 有哪些配伍禁忌 (Incompatibilities) 与协同增效组合?
推荐协同组合包括 GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL;配伍禁忌注意:Verify phase compatibility under extreme pH or high electrolyte loads。